Doctor profile · Federal record

Dr. Rohan Chawla, M.D.

Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Palm Harbor, FL

  • NPI 1437442183
  • Accepts Medicare
  • 15 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
33920 US Highway 19 N, Suite 241
Palm Harbor, FL 346842654
(727) 773-9793
fax (727) 773-0674

Credentials & registration

NPPES · NUCC
NPI registered
May 2011 — 15 yrs on file
Profile last updated
September 8, 2025
Year of graduation
2011 — 15 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
Florida #ME127169 · Louisiana #MD.207018

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1437442183. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
112,933
Distinct HCPCS
10
Medicare allowed
$1,881,176
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 38,000 15 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 22,400 25 $13
J3111 Injection, romosozumab-aqqg, 1 mg 19,320 16 $10
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 13,950 25 $42
J0897 Injection, denosumab, 1 mg 12,540 122 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,180 14 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 746 308 $124
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 653 146 $69
J7050 Infusion, normal saline solution, 250 cc 506 97 $1
96413 Administration of chemotherapy into vein, 1 hour or less 481 79 $122

In context: peer comparison

Among 4 peers in this city , average services per provider: 3,160. This provider delivers 36× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,622
Transactions
76
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 18 $300.70
ABBVIE INC. 15 $291.56
Janssen Biotech, Inc. 7 $174.18
PFIZER INC. 8 $141.06
UCB, Inc. 5 $108.80
Novartis Pharmaceuticals Corporation 4 $100.82
Lilly USA, LLC 4 $80.72
Alexion Pharmaceuticals, Inc. 3 $62.52
SCILEX PHARMACEUTICALS INC. 2 $48.10
Sandoz Inc. 2 $46.80
Radius Health, Inc. 2 $44.23
Alvogen Inc 2 $43.84
GENZYME CORPORATION 1 $33.29
E.R. Squibb & Sons, L.L.C. 1 $31.73
Genentech USA, Inc. 2 $27.99

By nature of payment

Food and Beverage
$1,622

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,859
Patients
601
Total drug cost
$59,087
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 461 149 $28,610
Methotrexate (Methotrexate Sodium) Brand 369 121 $10,948
Prednisone Generic 218 97 $2,885
Leflunomide Generic 155 45 $7,285
Tramadol Hcl Generic 113 23 $806
Alendronate Sodium Generic 98 41 $1,189
Folic Acid Generic 82 27 $592
Gabapentin Generic 75 20 $1,540
Allopurinol Generic 72 15 $744
Duloxetine Hcl Generic 67 17 $1,860

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Rohan Chawla's medical specialty?
Dr. Rohan Chawla practices Rheumatology Physician in Palm Harbor, FL.
Where does Dr. Rohan Chawla practice?
Dr. Rohan Chawla practices at 33920 US Highway 19 N, Palm Harbor, FL 346842654. Office phone: 7277739793.
What is Dr. Rohan Chawla's NPI?
Dr. Rohan Chawla's National Provider Identifier (NPI) is 1437442183, issued by NPPES.
Does Dr. Rohan Chawla accept Medicare assignment?
Yes. Dr. Rohan Chawla accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rohan Chawla commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.